Abigail L. Jenkins's Net Worth

-$25 Thousand

Estimate Recalculated Oct 2, 2024 01:17PM EST

Who is Abigail L. Jenkins?

Abigail L. Jenkins does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Gamida Cell Ltd., and Aquestive Therapeutics, Inc..

SEC CIK

Abigail L. Jenkins's CIK is 0001947032

Past Insider Trading and Trends

2023 was Abigail L. Jenkins's most active year for acquiring shares with 4 total transactions. Abigail L. Jenkins's most active month to acquire stocks was the month of September. 2024 was Abigail L. Jenkins's most active year for disposing of shares, totalling 1 transactions. Abigail L. Jenkins's most active month to dispose stocks was the month of April. 2022 saw Abigail L. Jenkins paying a total of $24,999.95 for 1,266,129 shares, this is the most they've acquired in one year. In 2024 Abigail L. Jenkins cashed out on 57,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Gamida Cell Ltd. (GMDA) No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+40.96%
109.01K
—
—
375.14K
Oct 19
Form 4/A
+1,550.00%
250K
—
—
266.13K
Oct 19
Form 4
+6.45%
16.13K
$1.55
$24,999.95
266.13K
Sep 30
Form 4
∞
250K
—
—
250K
Sep 19
Form 3
—
0
—
—
0
No matching records found

Aquestive Therapeutics, Inc. (AQST) Snapshot price: $4.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 10
Form 3
—
0
—
—
0
No matching records found